CareMax — Q1 2023 Earnings Presentation
14 slides from CareMax's earnings presentation, May 10, 2023
Slide 1: First Quarter 2023 Earnings Presentation
First Quarter 2023 Earnings Presentation May 10, 2023
Slide 2: Disclaimer
Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or
Slide 3: CareMax is Driven by a Mission to Deliver Best-in-Class Care
CareMax is Driven by a Mission to Deliver Best-in-Class Care ~96K Medicare Advantage Members1 62 CareMax Medical Centers1 5-Stars CMS Quality Rating2 ~268K Total Value-Based Care Members1 10 States1 As of March 31, 2023. Centers for Medicare & Medicaid Services 2022 Star rating across CareMax center
Slide 4: First Quarter 2023 Update
First Quarter 2023 Update Total Value-Based Care membership of 268,000, up 274% year-over year Medicare Advantage membership of 95,500, up 181% year-over-year Revenue of $173.0 million, up 26% year-over-year Net loss of $82.1 million, compared to net loss of $16.8 million for 1Q221 Adjusted EBITDA o
Slide 5: Value-Based Care Membership Breakdown
Value-Based Care Membership Breakdown ~268,000 Value-Based Care Lives ~95,500 Medicare Advantage1 Full-Risk 36% Other VBC2 62% ~33,500 Medicaid Other VBC2 97% ~33,500 Commercial Full-Risk 91% Other VBC2 9% ~107,000 MSSP & ACO REACH MSSP 92% ACO REACH 8% Note: As of March 31, 2023. 98% of MA patients
Slide 6: Reaffirming Financial Outlook for Full Year 2023
Reaffirming Financial Outlook for Full Year 2023 Note: Year over year growth may not compute due to rounding. Adjusted EBITDA is a non-GAAP number. For a reconciliation to the closest GAAP number, see supplement to this presentation. A reconciliation of projected 2023 Adjusted EBITDA to the most dir
Slide 7: First Quarter 2023 Financial Supplement
First Quarter 2023 Financial Supplement
Slide 8: Reconciliation to Platform Contribution and Calculation of Medical Expense Ratio
Reconciliation to Platform Contribution and Calculation of Medical Expense Ratio 1 2 Gross profit reflects the reclassification of stock compensation expense previously included in corporate, general and administrative expenses, which decreased gross profit by $0.4 million for the three months ended
Slide 9: Reconciliation to Adjusted EBITDA
Reconciliation to Adjusted EBITDA1 Net Income to Adjusted EBITDA Bridge 2 3 The Company has revised its presentation of Adjusted EBITDA to no longer add back de novo pre-opening costs and post-opening losses and has recast its prior presentation of Adjusted EBITDA. Represents initial costs to set up
Slide 10: Non-GAAP Adjustments Detail
Non-GAAP Adjustments Detail Represents consulting and legal costs directly associated with efforts related to integration of the two privately held companies that were combined in the Business Combination. Represents incremental compensation expense directly associated with efforts related to integr
Slide 11: Non-GAAP Financial Summary
Non-GAAP Financial Summary Adjusted EBITDA is calculated and presented after de novo pre-opening costs and post-opening losses. Non-GAAP Income Statement 1
Slide 12: Illustrative Financial Impact of Prior Period Developments
Illustrative Financial Impact of Prior Period Developments Excludes adjustments of approximately $0.3 million of other unfavorable prior period developments in revenue and $0.1 million of other favorable prior period developments in medical margin. Medicare and Medicaid risk medical margin equals Me
Slide 13: Capitalization and Liquidity
Capitalization and Liquidity Diluted Share Count Net Debt (Cash) Excludes unvested warrants as of March 31, 2023. Warrants have a strike price of $11.50/share and (other than the Related warrants) are subject to a $18.00 redemption cap. Warrants are currently out of the money based on CareMax’s clos
Slide 14: Q&A
Caremax Q&A